| Source: |
| Type: |
| H3K27ac is a histone modification that is associated with active gene expression. Here are some key points about H3K27ac and its relationship to cancer: Elevated in: breast, lung, colon, prostate ,Cancer stem cells and progenitor cells. High levels of H3K27ac are associated with poor prognosis in:Breast,Lung,CRC cancer. Low levels of H3K27ac are associated with good prognosis in: Certain types of leukemia and lymphoma (correlated with increased overall survival and disease-free survival). H3K27ac has been shown to play a role in the regulation of various oncogenes, including: MYC Cyclin D1 CDK4 Inhibition of H3K27ac has been shown to suppress tumor growth and induce apoptosis in various types of cancer. |
| 1028- | ASA, | Aspirin Suppressed PD-L1 Expression through Suppressing KAT5 and Subsequently Inhibited PD-1 and PD-L1 Signaling to Attenuate OC Development |
| - | vitro+vivo, | Ovarian, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:973 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid